LBO — JERSEY SHORE UNIVERSITY MED CTR
IRR: 18.3% | MOIC: 2.32x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.3%
IRR
2.32x
MOIC
$1.0B
Entry EV
$1.6B
Exit EV
$520.8M
Equity Invested
Sources & Uses
S&UTotal · $1.0B| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $393.1M | 38.8% | |
| Sub Debt | $98.3M | 9.7% | |
| Equity | $520.8M | 51.5% | |
| Enterprise Value | $982.6M | 97.1% | |
| Transaction Fees | $29.5M | 2.9% | |
| Total Uses | $1.0B | 100.0% |
Interpretation
INTAt 2.32x MOIC and 18.3% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $155.1M |
| Exit Ev | $1.6B |
| Net Debt At Exit | $421.7M |
| Equity At Exit | $1.2B |
| Equity Invested | $520.8M |
| Total Value Created | $685.9M |
| Value From Growth | $596.7M |
| Value From Multiple | $49.1M |
| Value From Deleveraging | $69.6M |